They are quoted as saying that: “Due to legal issues concerning patient privacy, we, as yet, are unable to implement exposure protocols and procedures.” As such, the group is recommending “an industry-wide moratorium on production” until certain details are confirmed and potential first- and second-generation exposures are identified. “FSC/APHSS cannot act on behalf of any testing facilities outside the APHSS system until we are requested to do so by the performer or any medical advisor authorized by the performer,” said the rep, adding the group has been in contact with “concerned parties” and has offered any assistance necessary.
The full FSC press-release can be viewed here. Curiously, that statement gives a flavour of the highly politicised and charged environment in which this announcement takes places. This rare scare (and it is just a scare at this point) raises questions of regulation and industry practice. Certain groups that have previously been involved in legal actions to bring about mandatory condom usage will no doubt once again spring into action.
Post a Comment